Copenhagen, Denmark - A team of Danish researchers have shown that certain patients with congestive heart failure (CHF) may benefit from the class III antiarrhythmic drug dofetilide (Tikosyn? - Pfizer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback